© Reuters /Landov © Reuters /Landov Distribution of Billionaires by Residence #317 Dilip Shanghvi Distribution of Billionaires by Residence #317 Dilip Shanghvi (Nilesh and I complement…) Vinita Gupta daughter of Lupin's promoter Deshbandhu Gupta and the face... (Nilesh and I complement…) Vinita Gupta , daughter of Lupin's promoter Deshbandhu Gupta and the face... Photo: Sun Pharmaceuticals HOME BUSINESS SLIDE SHOW Dilip Shanghvi Chairman Sun... Photo: Sun Pharmaceuticals HOME | BUSINESS | SLIDE SHOW Dilip Shanghvi , Chairman, Sun... T he combined entity will have revenues of $4.2 billion says a report from Centrum Broking. Ranjit... T he combined entity will have revenues of $4.2 billion, says a report from Centrum Broking. Ranjit... Mumbai April 7: Anlysts believe Sun Pharma owner Dilip Shanghvi possesses the Midas touch to turn... Mumbai, April 7: Anlysts believe Sun Pharma owner Dilip Shanghvi possesses the Midas touch to turn... What the Billionaires List Tells Us About Eme... Examining the rankings offers clues to which... What the Billionaires List Tells Us About Eme... Examining the rankings offers clues to which... Dilip Shanghvi among Asia's richest self-made billionaires Dilip Shanghvi among Asia's richest self-made billionaires S un Pharmaceutical Industries Chairman and Managing Director Dilip Shanghvi on Monday was named the... S un Pharmaceutical Industries Chairman and Managing Director Dilip Shanghvi on Monday was named the... O thers on the list include Lee Shau Kee of Hong Kong at the second position with net worth of $22.8... O thers on the list include Lee Shau Kee of Hong Kong at the second position with net worth of $22.8... Sun Pharma may slip below Rs 600: SP Tulsian Sun Pharma may slip below Rs 600: SP Tulsian A fillip to global ambitions The overseas business too will get a boost. In the US the Sun... A fillip to global ambitions The overseas business too will get a boost. In the US, the Sun... O ver the years the company grew manifold and made many acquisitions the latest being the $4... O ver the years, the company grew manifold and made many acquisitions, the latest being the $4... © Paul Cooper/Bloomberg News/Landov © Paul Cooper/Bloomberg News/Landov S un Pharma and Ranbaxy will lead the Indian market in as many as 13 therapeutic categories. Amongst... S un Pharma and Ranbaxy will lead the Indian market in as many as 13 therapeutic categories. Amongst... Sushmi Dey S un Pharma said it expects the acquisition to be accretive to earnings per share in the... Sushmi Dey S un Pharma said it expects the acquisition to be accretive to earnings per share in the...
Next »
Advanced Search